CELSIUS HOLDINGS INC (CELH)

US15118V2079 - Common Stock

27.01  -0.93 (-3.33%)

After market: 27.1484 +0.14 (+0.51%)

Fundamental Rating

6

CELH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 33 industry peers in the Beverages industry. While CELH has a great health rating, its profitability is only average at the moment. CELH shows excellent growth, but is valued quite expensive already. These ratings could make CELH a good candidate for growth investing.



6

1. Profitability

1.1 Basic Checks

In the past year CELH was profitable.
CELH had a positive operating cash flow in the past year.
Of the past 5 years CELH 4 years were profitable.
Of the past 5 years CELH 4 years had a positive operating cash flow.

1.2 Ratios

CELH's Return On Assets of 9.98% is fine compared to the rest of the industry. CELH outperforms 78.79% of its industry peers.
Looking at the Return On Equity, with a value of 13.63%, CELH is in line with its industry, outperforming 57.58% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.81%, CELH is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
ROA 9.98%
ROE 13.63%
ROIC 12.81%
ROA(3y)-1.06%
ROA(5y)2.87%
ROE(3y)-1.49%
ROE(5y)3.88%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CELH has a better Profit Margin (12.41%) than 72.73% of its industry peers.
In the last couple of years the Profit Margin of CELH has grown nicely.
Looking at the Operating Margin, with a value of 17.01%, CELH is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
CELH's Operating Margin has improved in the last couple of years.
CELH has a Gross Margin of 49.59%. This is comparable to the rest of the industry: CELH outperforms 57.58% of its industry peers.
CELH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.01%
PM (TTM) 12.41%
GM 49.59%
OM growth 3Y51%
OM growth 5YN/A
PM growth 3Y28.53%
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y3.67%

8

2. Health

2.1 Basic Checks

CELH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CELH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CELH has been increased compared to 5 years ago.
CELH has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 10.47 indicates that CELH is not in any danger for bankruptcy at the moment.
CELH has a Altman-Z score of 10.47. This is amongst the best in the industry. CELH outperforms 87.88% of its industry peers.
CELH has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
CELH has a Debt to FCF ratio of 0.00. This is amongst the best in the industry. CELH outperforms 90.91% of its industry peers.
CELH has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CELH (0.00) is better than 87.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.47
ROIC/WACC1.39
WACC9.21%

2.3 Liquidity

A Current Ratio of 4.71 indicates that CELH has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.71, CELH belongs to the top of the industry, outperforming 96.97% of the companies in the same industry.
CELH has a Quick Ratio of 4.03. This indicates that CELH is financially healthy and has no problem in meeting its short term obligations.
CELH has a better Quick ratio (4.03) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.71
Quick Ratio 4.03

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.00% over the past year.
Measured over the past years, CELH shows a very strong growth in Earnings Per Share. The EPS has been growing by 91.57% on average per year.
The Revenue has grown by 19.36% in the past year. This is quite good.
CELH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 90.45% yearly.
EPS 1Y (TTM)50%
EPS 3Y91.57%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)19.36%
Revenue growth 3Y116.05%
Revenue growth 5Y90.45%
Sales Q2Q%-30.93%

3.2 Future

CELH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.21% yearly.
CELH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.08% yearly.
EPS Next Y-8.84%
EPS Next 2Y10.6%
EPS Next 3Y15.09%
EPS Next 5Y18.21%
Revenue Next Year4.9%
Revenue Next 2Y10.19%
Revenue Next 3Y11.34%
Revenue Next 5Y12.08%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 37.51, CELH can be considered very expensive at the moment.
63.64% of the companies in the same industry are cheaper than CELH, based on the Price/Earnings ratio.
CELH's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.20.
Based on the Price/Forward Earnings ratio of 28.55, the valuation of CELH can be described as expensive.
CELH's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CELH to the average of the S&P500 Index (23.73), we can say CELH is valued slightly more expensively.
Industry RankSector Rank
PE 37.51
Fwd PE 28.55

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CELH.
CELH's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 37.41
EV/EBITDA 18.99

4.3 Compensation for Growth

The decent profitability rating of CELH may justify a higher PE ratio.
CELH's earnings are expected to grow with 15.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.6%
EPS Next 3Y15.09%

0

5. Dividend

5.1 Amount

No dividends for CELH!.
Industry RankSector Rank
Dividend Yield N/A

CELSIUS HOLDINGS INC

NASDAQ:CELH (12/20/2024, 8:01:16 PM)

After market: 27.1484 +0.14 (+0.51%)

27.01

-0.93 (-3.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)N/A N/A
Inst Owners72.45%
Inst Owner Change-10.69%
Ins Owners26.74%
Ins Owner Change-0.17%
Market Cap6.35B
Analysts80
Price Target42.54 (57.5%)
Short Float %18.36%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP16.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-42.81%
Min EPS beat(2)-100%
Max EPS beat(2)14.38%
EPS beat(4)3
Avg EPS beat(4)-10.29%
Min EPS beat(4)-100%
Max EPS beat(4)36.12%
EPS beat(8)6
Avg EPS beat(8)-4.8%
EPS beat(12)9
Avg EPS beat(12)19.52%
EPS beat(16)11
Avg EPS beat(16)17.26%
Revenue beat(2)1
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)0.24%
Revenue beat(4)2
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-10.55%
Max Revenue beat(4)2.75%
Revenue beat(8)5
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)5.71%
Revenue beat(16)13
Avg Revenue beat(16)8.1%
PT rev (1m)-7.04%
PT rev (3m)-33.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.8%
EPS NY rev (1m)-5.7%
EPS NY rev (3m)-29.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-28.33%
Revenue NY rev (1m)-2.52%
Revenue NY rev (3m)-10.49%
Valuation
Industry RankSector Rank
PE 37.51
Fwd PE 28.55
P/S 4.63
P/FCF 37.41
P/OCF 32.99
P/B 5.09
P/tB 5.2
EV/EBITDA 18.99
EPS(TTM)0.72
EY2.67%
EPS(NY)0.95
Fwd EY3.5%
FCF(TTM)0.72
FCFY2.67%
OCF(TTM)0.82
OCFY3.03%
SpS5.83
BVpS5.31
TBVpS5.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.98%
ROE 13.63%
ROCE 16.48%
ROIC 12.81%
ROICexc N/A
ROICexgc N/A
OM 17.01%
PM (TTM) 12.41%
GM 49.59%
FCFM 12.38%
ROA(3y)-1.06%
ROA(5y)2.87%
ROE(3y)-1.49%
ROE(5y)3.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y36.14%
ROICexcg growth 5YN/A
ROICexc growth 3Y62%
ROICexc growth 5YN/A
OM growth 3Y51%
OM growth 5YN/A
PM growth 3Y28.53%
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y3.67%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 379.26%
Cap/Sales 1.66%
Interest Coverage 250
Cash Conversion 80.45%
Profit Quality 99.75%
Current Ratio 4.71
Quick Ratio 4.03
Altman-Z 10.47
F-Score7
WACC9.21%
ROIC/WACC1.39
Cap/Depr(3y)407.35%
Cap/Depr(5y)253.69%
Cap/Sales(3y)1.2%
Cap/Sales(5y)0.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y91.57%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-8.84%
EPS Next 2Y10.6%
EPS Next 3Y15.09%
EPS Next 5Y18.21%
Revenue 1Y (TTM)19.36%
Revenue growth 3Y116.05%
Revenue growth 5Y90.45%
Sales Q2Q%-30.93%
Revenue Next Year4.9%
Revenue Next 2Y10.19%
Revenue Next 3Y11.34%
Revenue Next 5Y12.08%
EBIT growth 1Y27.71%
EBIT growth 3Y226.22%
EBIT growth 5YN/A
EBIT Next Year-7.89%
EBIT Next 3Y14.25%
EBIT Next 5Y16.35%
FCF growth 1Y38.83%
FCF growth 3Y253.59%
FCF growth 5YN/A
OCF growth 1Y52.16%
OCF growth 3Y246.31%
OCF growth 5YN/A